[ET Net News Agency, 3 July 2026] UBS raised the target price for Wuxi Bio (02269) to HKD51.1 from HKD49.3 and maintained the "buy" rating.
The research house said it revises up 2027-2029 revenue forecasts based on the promising three-year outlook. (rc)
The research house said it revises up 2027-2029 revenue forecasts based on the promising three-year outlook. (rc)